CAN
RARE icon

Cetera Advisor Networks’s Ultragenyx Pharmaceutical RARE Stock Holding History

Cetera Advisor Networks’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-325
Closed -$25K – 2606
2020
Q2 		$25K Buy
+325
New +$21.5K ﹤0.01% 2279

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cetera Advisor Networks's RARE Position: Q3 2020 in Review

Cetera Advisor Networks sold out of Ultragenyx Pharmaceutical (RARE) in Q3 2020, closing a stake of 325 shares — an estimated $25K sold.

Cetera Advisor Networks first reported a position in RARE in Q2 2020 and held it in 1 quarter. The position peaked at $25K in Q2 2020. 206 funds tracked by Wall St. Rank hold RARE as of Q3 2020.

  • Cetera Advisor Networks reported no remaining Ultragenyx Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • Cetera Advisor Networks sold 325 Ultragenyx Pharmaceutical shares in Q3 2020, an estimated $25K.
  • Cetera Advisor Networks first reported a position in Ultragenyx Pharmaceutical in Q2 2020 and held it in 1 quarter.
  • Cetera Advisor Networks's Ultragenyx Pharmaceutical position peaked at $25K in Q2 2020.
  • 206 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2020.

Based on Cetera Advisor Networks's 13F filing for Q3 2020, filed 13 Nov 2020.